BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8836010)

  • 1. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Semin Thromb Hemost; 1996; 22(3):255-9. PubMed ID: 8836010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
    Hara T; Yokoyama A; Tanabe K; Ishihara H; Iwamoto M
    Thromb Haemost; 1995 Aug; 74(2):635-9. PubMed ID: 8584999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DX-9065a, an orally active factor Xa inhibitor, does not facilitate haemorrhage induced by tail transection or gastric ulcer at the effective doses in rat thrombosis model.
    Tanabe K; Morishima Y; Shibutani T; Terada Y; Hara T; Shinohara Y; Aoyagi K; Kunitada S; Kondo T
    Thromb Haemost; 1999 May; 81(5):828-34. PubMed ID: 10365760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
    Herbert JM; Bernat A; Dol F; Hérault JP; Crépon B; Lormeau JC
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1030-8. PubMed ID: 8786532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa.
    Hara T; Yokoyama A; Ishihara H; Yokoyama Y; Nagahara T; Iwamoto M
    Thromb Haemost; 1994 Mar; 71(3):314-9. PubMed ID: 8029795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different antithrombotic properties of factor Xa inhibitor and thrombin inhibitor in rat thrombosis models.
    Furugohri T; Shiozaki Y; Muramatsu S; Honda Y; Matsumoto C; Isobe K; Sugiyama N
    Eur J Pharmacol; 2005 May; 514(1):35-42. PubMed ID: 15878322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological activity of amidinobicyclic compounds (derivatives of DX-9065a) as factor Xa inhibitors: SAR study of S1 and aryl binding sites.
    Komoriya S; Kanaya N; Nagahara T; Yokoyama A; Inamura K; Yokoyama Y; Katakura S; Hara T
    Bioorg Med Chem; 2004 May; 12(9):2099-114. PubMed ID: 15080912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
    Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific inhibitor of factor Xa, DX-9065a, exerts effective protection against experimental tumor induced disseminated intravascular coagulation in rats.
    Tanabe K; Terada Y; Shibutani T; Kunitada S; Kondo T
    Thromb Res; 1999 Oct; 96(2):135-43. PubMed ID: 10574591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ticlopidine and aspirin on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Furukawa Y; Takemura S; Kondo M
    Thromb Haemost; 1983 Jun; 49(3):190-2. PubMed ID: 6879507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
    Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
    Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin E on endotoxin-induced disseminated intravascular coagulation in rats.
    Yoshikawa T; Furukawa Y; Murakami M; Watanabe K; Kondo M
    Thromb Haemost; 1982 Oct; 48(2):235-7. PubMed ID: 7179203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6,7-Dihydroxy-3-phenylcoumarin inhibits thromboplastin induced disseminated intravascular coagulation.
    Tunali T; Yarat A; Bulut M; Emekli N
    Br J Haematol; 2004 Jul; 126(2):226-30. PubMed ID: 15238144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of factor Xa suppresses the expression of tissue factor in human monocytes and lipopolysaccharide-induced endotoxemia in rats.
    Akahane K; Okamoto K; Kikuchi M; Todoroki H; Higure A; Ohuchida T; Kitahara K; Takeda S; Itoh H; Ohsato K
    Surgery; 2001 Nov; 130(5):809-18. PubMed ID: 11685190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin and factor Xa enhance neutrophil chemoattractant production after ischemia/reperfusion in the rat liver.
    Yamaguchi Y; Okabe K; Liang J; Ohshiro H; Ishihara K; Uchino S; Zhang JL; Hidaka H; Yamada S; Ogawa M
    J Surg Res; 2000 Jul; 92(1):96-102. PubMed ID: 10864488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model.
    Olrik Berthelsen L; Thuri Kristensen A; Wiinberg B; Tranholm M
    Thromb Res; 2009 Sep; 124(4):490-7. PubMed ID: 19525002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of superoxide dismutase and catalase on disseminated intravascular coagulation in rats.
    Yoshikawa T; Murakami M; Yoshida N; Seto O; Kondo M
    Thromb Haemost; 1983 Dec; 50(4):869-72. PubMed ID: 6665768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants.
    Morishima Y; Tanabe K; Terada Y; Hara T; Kunitada S
    Thromb Haemost; 1997 Nov; 78(5):1366-71. PubMed ID: 9408021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.